Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France
Open Access
- 21 October 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 65 (12), 2620-2627
- https://doi.org/10.1093/jac/dkq380
Abstract
To estimate the prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-1-infected patients in France. Resistance mutations were sought in samples from 530 newly diagnosed HIV-1-infected patients from October 2006 to March 2007. Protease and reverse transcriptase mutations were identified from the 2007 Stanford Resistance Surveillance list. Reverse transcriptase and protease resistance mutations were determined in 466 patients with duration of seropositivity <5 years. 42% of patients were infected with non-B subtype strains (CRF02 18.3%). The overall prevalence of viruses with protease or reverse transcriptase mutations was 10.6% (95% confidence interval 6.7–16.3). The prevalence of protease inhibitor, nucleoside reverse transcriptase inhibitor and non-nucleoside reverse transcriptase inhibitor resistance-associated mutations was 4.7%, 5.8% and 2.8%, respectively. Frequency of resistance was not different in patients infected with B (9.5%) and non-B (CRF02 7.8% and other 11.2%) subtypes. Baseline characteristics such as gender, age, transmission group, country of transmission, disease stage, CD4 counts and viral load were not associated with the prevalence of transmitted drug resistance. In France in 2006/2007, the prevalence of transmitted drug-resistant variants was 10.6%. Prevalence of transmitted drug resistance was comparable in B and non-B subtypes. Prevalence of non-B subtypes is still rising.Keywords
This publication has 31 references indexed in Scilit:
- Transmission of Drug‐Resistant HIV‐1 Is Stabilizing in EuropeThe Journal of Infectious Diseases, 2009
- Performance of an immunoassay at detecting recent infection among reported HIV diagnosesAIDS, 2009
- The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infectionAIDS, 2009
- A public health model for the molecular surveillance of HIV transmission in San Diego, CaliforniaAIDS, 2009
- Transmission networks of drug resistance acquired in primary/early stage HIV infectionAIDS, 2008
- Phylogeny.fr: robust phylogenetic analysis for the non-specialistNucleic Acids Research, 2008
- HIV-1 protease and reverse transcriptase mutations for drug resistance surveillanceAIDS, 2007
- Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performanceJournal of Medical Virology, 2005
- Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical ManagementThe Journal of Infectious Diseases, 2005
- Development and Validation of an Immunoassay for Identification of Recent Human Immunodeficiency Virus Type 1 Infections and Its Use on Dried Serum SpotsJournal of Clinical Microbiology, 2005